Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Malignant Melanoma of Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00937482
What this trial is testing

Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Male Breast CancerStage IV Breast CancerStage IV Melanoma+7 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Active Not RecruitingNCT05176470
What this trial is testing

Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

Who this might be right for
Locally Advanced MelanomaPathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8+2 more
Richard Wu 2
Early research (Phase 1)UnknownNCT03385486
What this trial is testing

Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors

Who this might be right for
Stage III MelanomaStage IV Melanoma
Taiga Biotechnologies, Inc. 72
Large-scale testing (Phase 3)Active Not RecruitingNCT05732805
What this trial is testing

A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma

Who this might be right for
MelanomaMelanoma (Skin)Melanoma Stage III+4 more
Biocad 270
Early research (Phase 1)Ended earlyNCT01032122
What this trial is testing

Rituximab in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Medical University of Vienna 9
Not applicableStudy completedNCT00004153
What this trial is testing

Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma

Who this might be right for
Melanoma (Skin)
University of Chicago 106
Testing effectiveness (Phase 2)WithdrawnNCT00357461
What this trial is testing

Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Bristol-Myers Squibb
Not applicableStudy completedNCT01388569
What this trial is testing

Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 48
Testing effectiveness (Phase 2)Study completedNCT03278665
What this trial is testing

4SC-202 in Combination With Pembrolizumab in Patients Primary Refractory/Non-responding to Prior Anti-PD-1 Therapy

Who this might be right for
Malignant Melanoma
4SC AG 40
Testing effectiveness (Phase 2)Ended earlyNCT00863330
What this trial is testing

Laboratory-Treated Autologous Lymphocytes and Aldesleukin After Cyclophosphamide and Fludarabine in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Wake Forest University Health Sciences 14
Testing effectiveness (Phase 2)Ended earlyNCT00369395
What this trial is testing

Volociximab in Metastatic Melanoma

Who this might be right for
Stage IV Melanoma
Abbott 19
Early research (Phase 1)Ended earlyNCT01067066
What this trial is testing

A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Ended earlyNCT02748564
What this trial is testing

Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

Who this might be right for
Metastatic MelanomaStage III Mucosal Melanoma of the Head and NeckStage IIIA Skin Melanoma+6 more
Rutgers, The State University of New Jersey 10
Testing effectiveness (Phase 2)Study completedNCT00521053
What this trial is testing

Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma

Who this might be right for
Melanoma
Provectus Pharmaceuticals 80
Testing effectiveness (Phase 2)Study completedNCT00019721
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT06190951
What this trial is testing

A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 151
Testing effectiveness (Phase 2)Study completedNCT02519322
What this trial is testing

Neoadjuvant and Adjuvant Checkpoint Blockade

Who this might be right for
Cutaneous MelanomaMucosal MelanomaOcular Melanoma+8 more
M.D. Anderson Cancer Center 53
Testing effectiveness (Phase 2)Study completedNCT00072345
What this trial is testing

Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00722098
What this trial is testing

Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients

Who this might be right for
Malignant Melanoma Stage IV
Baylor Research Institute 9
Testing effectiveness (Phase 2)Study completedNCT06152367
What this trial is testing

Immunization With Autologous Dendritic Cells and Tumor Lysates in Melanoma Patients

Who this might be right for
Stage III Malignant Melanoma of Skin AJCC V6Stage IV Malignant Melanoma of Skin
University of Chile 90
Next Page